Thousands of bottles of blood pressure medication recalled nationwide ⁠6%

By Eric Revell⁠74%

6/22/2026, 2:30:31 PM

BS Summary: This article contains 8 faulty reasoning types, including Negativity Bias, Appeal to Emotion, and Recency Bias, with Appeal to Authority as the most egregious example at 37.2% saturation with 116 hits. Analysis detected 265 faulty-reasoning hits from 312 analyzed words, generating a BS Score of 22.4% and a BS Rank of ⁠6% (20,580 of 21,887 articles). This article is better (less manipulative) than 94.00% of the article peer group.

More than 11,000 bottles of blood pressure medication are being recalled nationwide due to a manufacturing defect, according to the Food and Drug Administration. 
The 11,460 bottles of chlorthalidone tablets, USP, 25 mg, are being recalled because of "failed dissolution specifications." 
Dissolution tests measure the release rate of a drug and its active ingredient from the tablet or capsule used as a dosage when it's placed into a liquid to assess the performance and quality of various drug formulations and batches, according to pharmaceutical company Pion. 
The recalled drugs were manufactured by Inventia Healthcare Limited of India – which initiated the voluntary recall – and distributed in the U.S. by Rising Pharma Holdings of East Brunswick, New Jersey. 
500K PACKAGES OF MACARONI AND CHEESE SOLD AT ALDI RECALLED OVER UNDECLARED SOY LECITHIN 
FOX Business reached out to Inventia Healthcare and Rising Pharma for comment. 
The Cleveland Clinic said that chlorthalidone is used to treat high blood pressure by helping kidneys remove fluid and salt from a user's blood through their urine. 
It's considered a diuretic drug and may also be used to reduce swelling related to heart, kidney or liver disease. 
DEADLY LISTERIA OUTBREAK SPARKS EXPANDED CHEESE RECALL ACROSS MULTIPLE STATES 
The recall was initiated voluntarily by the company on June 5 and is ongoing, according to the FDA's recall page. 
It covers 25 mg chlorthalidone tablets sold in either 100 or 1000 tablets per bottle as prescribed by a doctor. 
CDC URGES PARENTS TO STOP USING NARA ORGANICS INFANT FORMULA AFTER THREE BABIES HOSPITALIZED WITH BOTULISM 
The 100 tablet bottles covered by the recall have a batch code of RISA24001, while the 1000 tablet bottles have a batch code of RISB24002. 
The expiration date for bottles covered by the recall is April 2027. 
GET FOX BUSINESS ON THE GO BY CLICKING HERE 
Article reasoning-pattern comparisonThis article: 0.0%Eric Revell: 2.6%FoxBusiness: 4.4%Confirmation Bias0.0%This article: 0.0%Eric Revell: 4.7%FoxBusiness: 3.4%Anchoring Bias0.0%This article: 0.0%Eric Revell: 3.6%FoxBusiness: 4.1%Availability Heuristic0.0%This article: 0.0%Eric Revell: 1.3%FoxBusiness: 1.1%Representativeness Heuristic0.0%This article: 0.0%Eric Revell: 0.4%FoxBusiness: 0.7%Hindsight Bias0.0%This article: 0.0%Eric Revell: 3.0%FoxBusiness: 3.7%Overconfidence Bias0.0%This article: 0.0%Eric Revell: 11.0%FoxBusiness: 12.9%Framing Effect0.0%This article: 0.0%Eric Revell: 1.4%FoxBusiness: 1.5%Loss Aversion0.0%This article: 3.8%Eric Revell: 1.4%FoxBusiness: 1.1%Status Quo Bias3.8%This article: 0.0%Eric Revell: 0.1%FoxBusiness: 0.2%Sunk Cost Effect0.0%This article: 0.0%Eric Revell: 9.5%FoxBusiness: 8.8%Optimism Bias0.0%This article: 0.0%Eric Revell: 1.7%FoxBusiness: 2.0%Pessimism Bias0.0%This article: 15.7%Eric Revell: 6.9%FoxBusiness: 7.9%Negativity Bias15.7%This article: 0.0%Eric Revell: 2.5%FoxBusiness: 4.5%Self-Serving Bias0.0%This article: 0.0%Eric Revell: 0.5%FoxBusiness: 0.9%Fundamental Attribution Error0.0%This article: 0.0%Eric Revell: 0.0%FoxBusiness: 0.2%Actor-Observer Bias0.0%This article: 0.0%Eric Revell: 0.6%FoxBusiness: 1.7%In-Group Bias0.0%This article: 0.0%Eric Revell: 0.1%FoxBusiness: 0.8%Out-Group Homogeneity Bias0.0%This article: 0.0%Eric Revell: 3.1%FoxBusiness: 3.8%Halo Effect0.0%This article: 0.0%Eric Revell: 0.0%FoxBusiness: 0.1%Horn Effect0.0%This article: 0.0%Eric Revell: 0.0%FoxBusiness: 0.0%Dunning-Kruger Effect0.0%This article: 6.4%Eric Revell: 2.8%FoxBusiness: 2.3%Recency Bias6.4%This article: 0.0%Eric Revell: 0.4%FoxBusiness: 0.4%Primacy Effect0.0%This article: 0.0%Eric Revell: 0.1%FoxBusiness: 0.1%Blind-Spot Bias0.0%This article: 0.0%Eric Revell: 0.2%FoxBusiness: 0.8%Ad Hominem0.0%This article: 0.0%Eric Revell: 0.1%FoxBusiness: 0.4%Straw Man0.0%This article: 37.2%Eric Revell: 6.7%FoxBusiness: 7.2%Appeal to Authority37.2%This article: 0.0%Eric Revell: 1.2%FoxBusiness: 1.6%False Dilemma0.0%This article: 0.0%Eric Revell: 0.8%FoxBusiness: 1.2%Slippery Slope0.0%This article: 0.0%Eric Revell: 0.2%FoxBusiness: 0.2%Circular Reasoning0.0%This article: 0.0%Eric Revell: 4.2%FoxBusiness: 6.3%Hasty Generalization0.0%This article: 0.0%Eric Revell: 0.4%FoxBusiness: 0.8%Red Herring0.0%This article: 0.0%Eric Revell: 0.9%FoxBusiness: 1.2%Bandwagon0.0%This article: 8.3%Eric Revell: 3.4%FoxBusiness: 6.1%Appeal to Emotion8.3%This article: 0.0%Eric Revell: 0.8%FoxBusiness: 1.2%Begging the Question0.0%This article: 0.0%Eric Revell: 3.9%FoxBusiness: 4.4%Post Hoc (False Cause)0.0%This article: 0.0%Eric Revell: 0.0%FoxBusiness: 0.1%Tu Quoque0.0%This article: 0.0%Eric Revell: 0.1%FoxBusiness: 0.4%Burden of Proof0.0%This article: 0.0%Eric Revell: 0.1%FoxBusiness: 0.1%Appeal to Nature0.0%This article: 0.0%Eric Revell: 0.2%FoxBusiness: 0.3%Composition/Division0.0%This article: 0.0%Eric Revell: 1.0%FoxBusiness: 2.4%Anecdotal0.0%This article: 0.0%Eric Revell: 0.0%FoxBusiness: 0.1%No True Scotsman0.0%This article: 0.0%Eric Revell: 2.1%FoxBusiness: 1.9%Ambiguity (Equivocation)0.0%This article: 0.0%Eric Revell: 0.0%FoxBusiness: 0.0%Gambler’s Fallacy0.0%This article: 0.0%Eric Revell: 0.2%FoxBusiness: 0.1%Middle Ground0.0%This article: 0.0%Eric Revell: 0.1%FoxBusiness: 0.1%Personal Incredulity0.0%This article: 0.0%Eric Revell: 0.1%FoxBusiness: 0.3%Special Pleading0.0%This article: 0.0%Eric Revell: 0.1%FoxBusiness: 0.2%Genetic Fallacy0.0%This article: 5.4%Eric Revell: 1.3%FoxBusiness: 1.8%Unattributed Quote5.4%This article: 0.0%Eric Revell: 0.9%FoxBusiness: 1.4%Quote-first Misdirection0.0%This article: 0.0%Eric Revell: 3.2%FoxBusiness: 4.1%Biased Writer Voice0.0%This article: 5.1%Eric Revell: 1.9%FoxBusiness: 1.7%Indoctrination5.1%This article: 0.0%Eric Revell: 0.0%FoxBusiness: 0.1%Politically Left Leaning Bias0.0%This article: 0.0%Eric Revell: 0.7%FoxBusiness: 2.1%Politically Right Leaning Bias0.0%This article: 2.9%Eric Revell: 2.8%FoxBusiness: 4.4%Attempt to Sell a Product or S…2.9%

312 words analyzed.

Speakers

4speakers47%attributed speech164writer words
Voice mapSelect a segment to jump to its words
Writer's voice • 9 words • 0.0% coverageFood and Drug Administration • 24 words • 0.0% coverageWriter's voice • 17 words • 100.0% coveragepharmaceutical company Pion • 45 words • 0.0% coverageInventia Healthcare Limited • 32 words • 0.0% coverageWriter's voice • 14 words • 0.0% coverageWriter's voice • 12 words • 0.0% coverageCleveland Clinic • 27 words • 0.0% coverageWriter's voice • 20 words • 0.0% coverageWriter's voice • 10 words • 0.0% coverageFood and Drug Administration • 20 words • 0.0% coverageWriter's voice • 20 words • 0.0% coverageWriter's voice • 16 words • 100.0% coverageWriter's voice • 25 words • 0.0% coverageWriter's voice • 12 words • 0.0% coverageWriter's voice • 9 words • 100.0% coverage
100%flagged-word coverage
44 attributed words30% of attributed speech53% writer coverage
0%7.5%15.0%Unattributed Quote-10.4 ptsWriter: 10.4%Food and Drug Administration: 0.0%0.0%Indoctrination-9.8 ptsWriter: 9.8%Food and Drug Administration: 0.0%0.0%Attempt to Sell a Product -5.5 ptsWriter: 5.5%Food and Drug Administration: 0.0%0.0%

Attribution is sentence-level. Pattern percentages are calculated only from words assigned to that voice.

Loading…
Loading…
Loading…
Loading…

Analysis

Hover over highlighted words in the article to view the associated bias or fallacy analysis.